Zagouri F, Bago-Horvath Z, Rössler F, Brandstetter A, Bartsch R, Papadimitriou CA, Dimitrakakis C, Tsigginou A, Papaspyrou I, Giannos A, et al. High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer. British Journal of Cancer [Internet]. 2013;108(5):1100 - 1105.